Atlas Trials

Locally Advanced Pancreatic Cancer Treated With ABLAtivE Stereotactic MRI-guided Adaptive Radiation Therapy

Clinical trial NCT05585554 · NOT_YET_RECRUITING

Trial details

NCT number
NCT05585554
Sponsor
Viewray Inc.
Status
NOT_YET_RECRUITING
Phase
Not Applicable
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2023-07-01
Primary completion
2028-08-01
Enrollment
267

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.